Publication | Closed Access

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension

Metabolic SyndromeHypertensionAngiotensin-converting Enzyme InhibitorsAlzheimer's DiseaseCardiovascular DiseaseAntihypertensive TherapyDementiaDiabetesPharmacologyDementia RiskVascular DementiaNeurologyDiabetes MellitusAging-associated DiseaseMedicineRisk FactorsHealth Sciences